MaxCyte the global cellbased therapies and life sciences company and KSQ Therapeutics a biotechnology company using its proprietary CRISPRomics discovery platform to achieve higher probabilities of success in drug development announced today that the companies have entered into a new development and...

Zionexa a radiopharmaceutical company specialized in the development and commercialization of invivo biomarkers for use in guiding targeted therapies in oncology and PETNET Solutions Inc a Siemens Healthineers company specializing in the manufacturing and distribution of positron emission tomography...

Gatehouse Bio a pioneer in nextgeneration therapeutics is collaborating with AstraZeneca a global scienceled biopharmaceutical company to explore the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bios Artificial Intelligence AIpowered platform

LEO Pharma AS and Portal Instruments today announced a global collaboration and license agreement to develop Portals innovative needlefree drug delivery system for use in combination with LEO Pharmas portfolio of investigational and approved medicines

RAPT Therapeutics Inc a clinicalstage immunologybased biopharmaceutical company focused on discovering developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases and Hanmi Pharmaceutical Co LTD today announced a licens...

Resonant Therapeutics Inc announced that the company has entered into an agreement with Janssen Research and Development LLC Janssen with the aim to discover and validate novel tumor and immunological targets and to validate certain therapeutic candidates

Neurocrine Biosciences Inc and Xenon Pharmaceuticals Inc announced a license and collaboration agreement to develop firstinclass treatments for epilepsyNeurocrine Biosciences gains an exclusive license to XEN a clinical stage selective Nav sodium channel inhibitor with potential in SCNA developmenta...

Astellas Pharma Inc and Audentes Therapeutics Inc today announced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US per share in cash representing a total equity value of approximately US billionRecent scientific and technological advances in geneti...

Innovent Biologics Inc Innovent or the Company HKEX a worldclass biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major diseases today announced that the new drug application NDA submitted by Incyte to the...

The M expansion has tripled the facilitys footprint to approximately sq ft significantly expanding capacity and supporting MedPharms continued commitment to the topical and transdermal market

Galectin Therapeutics Inc the leading developer of therapeutics that target galectin proteins recently presented its current plans for an Adaptively Designed Phase clinical trial NASHRX of its lead compound belapectin GRMD in the treatment of patients with nonalcoholic steatohepatitis NASH cirrhosi...

Alector Inc a clinical stage biotechnology company pioneering immunoneurology today announced that the US Food and Drug Administration FDA has granted Fast Track designation for its investigational therapeutic AL for the treatment of patients with frontotemporal dementia FTD carrying specific geneti...

Schreiner MediPharm a specialist in innovative functional labels for the pharmaceutical industry and PragmatIC a world leader in low cost flexible electronics have entered into a strategic partnership The purpose of the cooperation is to offer manufacturers of pharmaceutical products and medical dev...

Eisai Co Ltd announced today that three oral presentations and eight poster presentations highlighting the latest data on its Alzheimers disease dementia pipeline including antiamyloid beta Abeta protofibril antibody BAN orexin receptor antagonist lemborexant and a simple blood diagnostic for Alzhe...

The Emirates Society of Emergency Medicine Conference ESEM is going to be held from th to Th of December at the Jumeirah At Etihad Towers in Abu Dhabi United Arab Emirates ESEM conference is the largest ongoing annual gathering on emergency medicine in the middle east primarily in the areas of Pre...

Tetra BioPharma Inc a leader in cannabinoidderived drug discovery and development today announced it has received US Food and Drug Administration FDA Orphan Drug Designation for deltatetrahydrocannabinol THC in the treatment of hepatocellular carcinoma

Adastra Pharmaceuticals Inc a biopharmaceutical company focused on the development of firstinclass therapeutics for the treatment of cancer today announced that the US Food and Drug Administration FDA and the European Medicines Agency EMA have granted Orphan Drug Designation to zotiraciclib for the...

Piramal Enterprises Limiteds Pharma Solutions business a leading Contract Development and Manufacturing Organization CDMO today announced that the company will be partnering with BerGenBio ASA OSE BGBIO on the development of bemcentinib for the treatment of elderly patients with relapsed Acute Myelo...